The Firm represented the initial purchasers in connection with an offering by Bausch + Lomb Netherlands B.V. and Bausch & Lomb Incorporated, subsidiaries of Bausch + Lomb Corporation (“Bausch + Lomb”), consisting of €675 million aggregate principal amount of Senior Secured Floating Rate Notes due 2031 pursuant to Rule 144A and Regulation S.
In addition, the Firm represented JPMorgan Chase Bank, N.A. and the other lead arrangers in connection with Bausch + Lomb’s entry into a $2.325 billion term loan B facility and an $800 million revolving credit facility.
The proceeds from the transactions were used to refinance certain of Bausch + Lomb’s existing debt facilities and to pay related fees and expenses.
Bausch + Lomb is a leading global eye health company with a comprehensive portfolio of contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.
The Simpson Thacher team included John C. Ericson, John O’Connell, Traci Biedermann, Olivia Pepper and Michael Tremeski (Capital Markets); Daniel Kay, Robert Meyer, Sophie Skinner and Sally Jo (Banking & Credit); Vanessa Burrows and Jacob Madden (Healthcare); Jonathan Pall (Collateral); Courtney Welshimer, Alysha Sekhon and Paige Brinton (Intellectual Property); Michael Mann (Tax); Jeanne Annarumma, Ryan Stott and Radhika Tahiliani (Executive Compensation & Employee Benefits); and Andrew Pagliughi (FINRA and Blue Sky). Summer Associates Emma Yi Li, Ryan Hayden Alexander, and Shirin Maani also provided valuable assistance